Improve the traceability of the entire production and distribution of essential drugs

The General Office of the State Council has recently issued the "Five Key Reforms of the Medical and Health System in 2011" (hereinafter referred to as the "Work Arrangement"), which clarifies the general requirements, work tasks, and safeguard measures. Among them, in the preliminary establishment of a national essential drug system, the "Working Arrangements" proposed that basic drug production and supply should be guaranteed and basic drug supervision should be strengthened.

Five major reforms in the medical and health system The main tasks for 2011 were to expedite the establishment of a basic medical insurance system, initially establish a national essential medicine system, improve the medical and health service system, promote the gradual equalization of basic public health services, and actively and steadily advance the reform of public hospitals.

In the initial establishment of a national basic drug system, the first is to expand the scope of implementation of the basic drug system and achieve full coverage at the grassroots level. In all government-run grass-roots medical and health institutions, the implementation of the national essential medicine system, the implementation of zero-dip sales. The second is to establish a mechanism for standardizing the procurement of essential drugs and to reshape the supply guarantee system for primary drugs. The basic drugs used by the government-administered primary medical and health institutions that implement the basic drug system (including supplementary varieties of provinces, districts, and cities) shall be centralized purchasing and unified distribution by province (region, city) as a unit to ensure basic drugs are safe, effective, and of good quality. , Reasonable price, timely supply. Ensure the supply and supply of essential drugs. It is up to the supplier to independently choose to run the company for distribution or to distribute itself. Encourage the development of modern logistics and other means to improve distribution efficiency. Promote pharmaceutical production and distribution companies to optimize the structure and achieve scale operations. Full implementation of new national standards for essential drug quality. Strengthen the supervision of essential drugs, speed up the construction of information systems, carry out full-species coverage testing of essential drugs and electronic surveillance of all varieties, and enhance the ability to trace the entire process of basic drugs from production to circulation. Third, comprehensively promote the comprehensive reform of primary health care institutions and establish new operating mechanisms.